• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    89 Biggest Movers From Friday

    6/21/22 4:44:52 AM ET
    $ADN
    $ADXN
    $AKRO
    $ALLK
    Industrial Machinery/Components
    Miscellaneous
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADN alert in real time by email

    Gainers

    • Revlon, Inc. (NYSE:REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy.
    • Grove Collaborative Holdings, Inc. (NYSE:GROV) rose 67.9% to close at $10.00. Grove Collaborative and Virgin Group Acquisition Corp. II announced the completion of their previously announced business combination.
    • Mereo BioPharma Group plc (NASDAQ:MREO) gained 62.5% to close at $1.30. AstraZeneca is rumored to be eyeing takeover of Mereo BioPharma Group, according to a report in The Times.
    • SoundHound AI, Inc. (NASDAQ:SOUN) climbed 49.8% to close at $4.44.
    • Swvl Holdings Corp. (NASDAQ:SWVL) gained 35.3% to settle at $6.90.
    • Clovis Oncology, Inc. (NASDAQ:CLVS) surged 31.9% to close at $1.18. Clovis Oncology recently announced a presentation detailing initial Phase 1 data from Phase 1/2 LuMIERE clinical study of FAP-2286 labeled with lutetium-177 (177Lu-FAP-2286).
    • Jupiter Wellness, Inc. (NASDAQ:JUPW) jumped 31.4% to close at $0.80. Jupiter Wellness retired approximately 10% of its outstanding shares.
    • Satellogic Inc. (NASDAQ:SATL) jumped 29.6% to close at $5.04.
    • Electric Last Mile Solutions, Inc. (NASDAQ:ELMS) gained 29.4% to close at $0.3650 after jumping 100% on Thursday.
    • Sesen Bio, Inc. (NASDAQ:SESN) climbed 29.2% to close at $0.76.
    • Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) jumped 28.8% to close at $0.3002.
    • Virgin Orbit Holdings, Inc. (NASDAQ:VORB) gained 28.1% to close at $3.51.
    • Cipher Mining Inc. (NASDAQ:CIFR) gained 27.3% to settle at $1.82.
    • Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) gained 26.9% to close at $4.44. Comera was granted U.S. patent titled 'Excipient compounds for protein processing.'
    • Clear Channel Outdoor Holdings, Inc. (NYSE:CCO) jumped 26.6% to settle at $1.38.
    • Tivic Health Systems, Inc. (NASDAQ:TIVC) rose 26.3% to close at $2.40. Tivic Health Systems, during May, reported a Q1 loss of $0.23 per share.
    • Starry Group Holdings, Inc. (NYSE:STRY) gained 26% to close at $5.18. Cowen & Co. initiated coverage on Starry Group Holdings with an Outperform rating and announced a price target of $9.
    • XpresSpa Group, Inc. (NASDAQ:XSPA) gained 24.6% to close at $0.86.
    • Secoo Holding Limited (NASDAQ:SECO) rose 24% to settle at $0.2874. Secoo received approval to transfer to Nasdaq Capital Market.
    • Symbotic Inc. (NASDAQ:SYM) gained 23.8% to close at $16.80.
    • Altimmune, Inc. (NASDAQ:ALT) surged 22.9% to settle at $9.02.
    • Pharvaris N.V. (NASDAQ:PHVS) jumped 22.1% to close at $27.50.
    • Virco Mfg. Corporation (NASDAQ:VIRC) gained 21.9% to close at $3.67.
    • MINISO Group Holding Limited (NYSE:MNSO) climbed 21.8% to close at $7.67.
    • Sana Biotechnology, Inc. (NASDAQ:SANA) gained 21.5% to close at $5.15.
    • Jerash Holdings (US), Inc. (NASDAQ:JRSH) jumped 20.2% to settle at $6.70. Jerash Holdings’ board recently authorized a $3 million buyback.
    • Crexendo, Inc. (NASDAQ:CXDO) surged 20.1% to settle at $3.23.
    • Lyell Immunopharma, Inc. (NASDAQ:LYEL) jumped 20% to close at $5.46.
    • PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS) rose 19.8% to close at $0.6201.
    • Zai Lab Limited (NASDAQ:ZLAB) jumped 19.8% to close at $27.73. Zai Lab recently announced breakthrough therapy designations granted for Repotrectinib in China.
    • Rocky Mountain Chocolate Factory, Inc. (NASDAQ:RMCF) jumped 19.6% to settle at $8.25. Rocky Mountain Chocolate, last month, posted Q4 EPS of $0.01.
    • Centessa Pharmaceuticals plc (NASDAQ:CNTA) gained 19.1% to close at $4.93 after BRMO Capital initiated coverage on the stock with an Outperform rating and $19 price target.
    • Sonder Holdings Inc. (NASDAQ:SOND) surged 18.8% to close at $1.52.
    • Helbiz, Inc. (NASDAQ:HLBZ) climbed 18.6% to close at $0.83.
    • REE Automotive Ltd. (NASDAQ:REE) jumped 18.6% to close at $1.53.
    • Rubius Therapeutics, Inc. (NASDAQ:RUBY) gained 18.4% to settle at $0.9323.
    • Lilium N.V. (NASDAQ:LILM) gained 18% to close at $2.69.
    • Heritage Global Inc. (NASDAQ:HGBL) jumped 17.8% to close at $1.55.
    • Cogent Biosciences, Inc. (NASDAQ:COGT) jumped 17.8% to close at $9.19. Cogent Biosciences recently announced a proposed public offering of $125 million of common stock.
    • Q&K International Group Limited (NASDAQ:QK) gained 17.7% to settle at $1.60.
    • Velocity Financial, Inc. (NYSE:VEL) rose 17.6% to close at $11.64.
    • BridgeBio Pharma, Inc. (NASDAQ:BBIO) gained 17.5% to close at $7.65.
    • Mersana Therapeutics, Inc. (NASDAQ:MRSN) jumped 17.5% to close at $3.70.
    • Akero Therapeutics, Inc. (NASDAQ:AKRO) surged 17.3% to settle at $12.16. Akero Therapeutics announced a $25 million equity investment by Pfizer at $9.90 per share.
    • Quotient Limited (NASDAQ:QTNT) gained 17.2% to settle at $0.3599.
    • Dyne Therapeutics, Inc. (NASDAQ:DYN) rose 17.2% to close at $5.94.
    • Synlogic, Inc. (NASDAQ:SYBX) surged 16.6% to close at $1.04.
    • Bit Digital, Inc. (NASDAQ:BTBT) jumped 16.4% to close at $1.42.
    • Allogene Therapeutics, Inc. (NASDAQ:ALLO) gained 16.4% to close at $ 10.96.
    • Allogene Therapeutics recently said that the FDA granted regenerative medicine advanced therapy designation to ALLO-501A for Large B Cell Lymphoma.
    • Stem, Inc. (NYSE:STEM) rose 16.4% to settle at $7.30.
    • bluebird bio, Inc. (NASDAQ:BLUE) shares gained 16.3% to close at $3.56. The FDA's Advisory Committee recently unanimously backed Bluebird bio’s gene therapy for a rare blood disorder.
    • Atara Biotherapeutics, Inc. (NASDAQ:ATRA) rose 16.2% to close at $5.87.
    • Scopus BioPharma Inc. (NASDAQ:SCPS) jumped 15.9% to settle at $0.4250.
    • Vaxart, Inc. (NASDAQ:VXRT) gained 15.6% to close at $3.12.
    • Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) jumped 15.3% to close at $7.62.
    • Allakos Inc. (NASDAQ:ALLK) gained 14.2% to close at $2.97.
    • Kinnate Biopharma Inc. (NASDAQ:KNTE) rose 13.7% to close at $9.36.
    • Seagen Inc. (NASDAQ:SGEN) shares rose 12.7% to close at $165.45. Merck is eyeing purchase of biotech Seagen, while other unnamed suitors are also eyeing Seagen, the Wall Street Journal said.
    • Calliditas Therapeutics AB (NASDAQ:CALT) rose 12% to close at $17.82.
    • Scholar Rock Holding Corporation (NASDAQ:SRRK) shares rose 10.9% to close at $5.39. Scholar Rock reported Phase 2 topaz trial extension data showing 'sizable and sustained motor function improvement at 24 months with apitegromab for non-ambulatory patients with types 2 and 3 spinal muscular atrophy.'
    • Sapiens International Corporation N.V. (NASDAQ:SPNS) climbed 10.9% to close at $23.22.
    • Sight Sciences, Inc. (NASDAQ:SGHT) jumped 10.4% to close at $8.27.
    • Surrozen, Inc. (NASDAQ:SRZN) gained 8.6% to close at $2.41. Surrozen recently initiated dosing in Phase 1 clinical trial of SZN-043 for severe alcoholic hepatitis.

     


    Losers

    • Renovare Environmental, Inc (NASDAQ:RENO) fell 64.7% to close at $0.06 on Friday.
    • Addex Therapeutics Ltd (NASDAQ:ADXN) shares declined 58.3% to settle at $1.50 after the company terminated its Phase 2b/3 study of Dipraglurant for dyskinesia associated with Parkinson's disease due to slow recruitment. The company suspended its guidance amid the termination.
    • ToughBuilt Industries, Inc. (NASDAQ:TBLT) fell 51.5% to close at $1.48 after the company priced a $6 million offering.
    • Advent Technologies Holdings, Inc. (NASDAQ:ADN) declined 27.6% to close at $2.89. Advent Technologies recently announced it received notification of euro 782.1 million of funding from the Greek State for the IPCEI Green HiPo project.
    • Bon Natural Life Limited (NASDAQ:BON) fell 23% to close at $2.85.
    • Axcella Health Inc. (NASDAQ:AXLA) dropped 22.7% to close at $1.80.
    • Pennsylvania Real Estate Investment Trust (NYSE:PEI) shares declined 20.5% to close at $4.23.
    • Sidus Space, Inc. (NASDAQ:SIDU) fell 19.3% to close at $6.16.
    • Equillium, Inc. (NASDAQ:EQ) declined 16.7% to settle at $1.75.
    • NeuroPace, Inc.(NASDAQ:NPCE) fell 16% to close at $5.03.
    • Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) dropped 15.7% to close at $2.42.
    • Innate Pharma S.A. (NASDAQ:IPHA) fell 15.3% to close at $2.00.
    • Applied UV, Inc. (NASDAQ:AUVI) declined 15.2% to close at $2.45.
    • AN2 Therapeutics, Inc. (NASDAQ:ANTX) fell 15.1% to settle at $8.51.
    • Neptune Wellness Solutions Inc. (NASDAQ:NEPT) declined 14.7% to close at $2.32. Neptune Wellness appointed Raymond Silcock as Chief Financial Officer.
    • Vertex Energy, Inc. (NASDAQ:VTNR) fell 14.5% to settle at $11.82.
    • Mesa Royalty Trust (NYSE:MTR) declined 14.5% to close at $14.96.
    • Northern Oil and Gas, Inc. (NYSE:NOG) fell 14.4% to close at $27.52.
    • Hillstream BioPharma, Inc. (NASDAQ:HILS) dropped 14.4% to close at $0.78.
    • Alvotech Ordinary Shares (NASDAQ:ALVO) fell 14.1% to close at $9.70.
    • Heart Test Laboratories, Inc. (NASDAQ:HSCS) dropped 14.1% to close at $2.0777. Heart Test Laboratories announced pricing of its IPO of 1.5 million units at a price of $4.25 per unit.
    • Athersys, Inc. (NASDAQ:ATHX) fell 12.9% to close at $0.2789 after dropping more than 12% on Thursday.
    • Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) declined 12.1% to close at $10.15.
    • Vivakor, Inc. (NASDAQ:VIVK) fell 10.4% to close at $2.23. Vivakor shares jumped 40% on Thursday after the company announced it signed a definitive agreement to acquire Silver Fuels Delhi and White Claw Colorado City.
    • Dream Finders Homes, Inc. (NASDAQ:DFH) dipped 10% to close at $10.64. B of A Securities downgraded Dream Finders Homes from Neutral to Underperform and lowered the price target from $18 to $10.5.
    • Range Resources Corporation (NYSE:RRC) fell 9.9% to close at $26.29.
    Get the next $ADN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADN
    $ADXN
    $AKRO
    $ALLK

    CompanyDatePrice TargetRatingAnalyst
    Equillium Inc.
    $EQ
    2/25/2026$5.00Buy
    Stifel
    Centessa Pharmaceuticals plc
    $CNTA
    2/24/2026$40.00Outperform
    Wolfe Research
    Satellogic Inc.
    $SATL
    2/20/2026$7.00Overweight
    Cantor Fitzgerald
    Surrozen Inc.
    $SRZN
    2/19/2026$40.00Overweight
    Cantor Fitzgerald
    Satellogic Inc.
    $SATL
    2/18/2026$5.50Outperform
    Northland Capital
    Cipher Digital Inc.
    $CIFR
    2/9/2026$38.00Overweight
    Morgan Stanley
    BridgeBio Pharma Inc.
    $BBIO
    1/28/2026$157.00Overweight
    Barclays
    Altimmune Inc.
    $ALT
    1/28/2026$20.00Overweight
    Barclays
    More analyst ratings

    $ADN
    $ADXN
    $AKRO
    $ALLK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Tcg Crossover Gp Ii, Llc bought $444,844 worth of shares (18,856 units at $23.59) (SEC Form 4)

    4 - Surrozen, Inc./DE (0001824893) (Issuer)

    2/13/26 4:19:53 PM ET
    $SRZN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Large owner Tcg Crossover Gp Ii, Llc bought $202,534 worth of shares (9,357 units at $21.65) (SEC Form 4)

    4 - Surrozen, Inc./DE (0001824893) (Issuer)

    2/3/26 8:03:54 PM ET
    $SRZN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Large owner Global Value Investment Corp. bought $22,353 worth of shares (11,300 units at $1.98) (SEC Form 4)

    4 - Rocky Mountain Chocolate Factory, Inc. (0001616262) (Issuer)

    1/22/26 9:55:04 PM ET
    $RMCF
    Specialty Foods
    Consumer Staples

    $ADN
    $ADXN
    $AKRO
    $ALLK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Stifel initiated coverage on Equillium with a new price target

    Stifel initiated coverage of Equillium with a rating of Buy and set a new price target of $5.00

    2/25/26 7:52:10 AM ET
    $EQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Wolfe Research initiated coverage on Centessa Pharmaceuticals with a new price target

    Wolfe Research initiated coverage of Centessa Pharmaceuticals with a rating of Outperform and set a new price target of $40.00

    2/24/26 7:47:48 AM ET
    $CNTA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cantor Fitzgerald initiated coverage on Satellogic with a new price target

    Cantor Fitzgerald initiated coverage of Satellogic with a rating of Overweight and set a new price target of $7.00

    2/20/26 8:25:25 AM ET
    $SATL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $ADN
    $ADXN
    $AKRO
    $ALLK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Calumet Reports Fourth Quarter and Fiscal Year 2025 Results

    Fiscal Year 2025 net loss of $33.8 million, or basic loss per common share of $0.39Fiscal Year 2025 Adjusted EBITDA with Tax Attributes of $293.3 million$222 million of recourse debt reduction in 2025Strong free cash flow driven by approximately $100 million of cost reduction initiatives in 2025Record production year in Specialty Products & Solutions segment and Montana RenewablesMontana Renewables MaxSAF®150 expansion on track for second quarter of 2026INDIANAPOLIS, Feb. 27, 2026 /PRNewswire/ -- Calumet, Inc. (NASDAQ:CLMT) (the "Company," "Calumet," "we," "our" or "us")  today reported its results for the fourth quarter and year ended December 31, 2025, as follows: Three Months Ended Decemb

    2/27/26 7:00:00 AM ET
    $CLMT
    Integrated oil Companies
    Energy

    Range Increases Quarterly Dividend By 11%

    FORT WORTH, Texas, Feb. 27, 2026 (GLOBE NEWSWIRE) -- RANGE RESOURCES CORPORATION (NYSE:RRC) today announced that its Board of Directors declared a quarterly cash dividend on its common stock for the first quarter. A dividend of $0.10 per common share is payable on March 27, 2026 to stockholders of record at the close of business on March 13, 2026. This represents an 11% increase to Range's quarterly cash dividend and provides an annualized dividend of $0.40 per share. RANGE RESOURCES CORPORATION (NYSE:RRC) is a leading U.S. independent natural gas and NGL producer with operations focused in the Appalachian Basin. The Company is headquartered in Fort Worth, Texas.  More information about R

    2/27/26 7:00:00 AM ET
    $RRC
    Oil & Gas Production
    Energy

    Rocky Mountain Chocolate Factory Launches Omnichannel Growth Strategy; Systemwide Rollout Underway

    DURANGO, Colo., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Rocky Mountain Chocolate Factory, Inc. (NASDAQ:RMCF), America's Chocolatier®, today announced the launch of its omnichannel growth strategy, marking the next phase of the company's broader transformation initiative. Systemwide rollout is underway and expected to be substantially implemented over the next six weeks. For more than 40 years, the company has delivered a premium five-senses retail experience through handcrafted chocolates, live caramel apple dipping, in-store fudge making, and immersive confectionery theater. As Rocky Mountain Chocolate Factory continues modernizing its store prototype and expanding into new territories, the om

    2/26/26 11:00:00 AM ET
    $RMCF
    Specialty Foods
    Consumer Staples

    $ADN
    $ADXN
    $AKRO
    $ALLK
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ATTRUBY issued to BRIDGEBIO PHARMA INC

    Submission status for BRIDGEBIO PHARMA INC's drug ATTRUBY (ORIG-1) with active ingredient ACORAMIDIS has changed to 'Approval' on 11/22/2024. Application Category: NDA, Application Number: 216540, Application Classification: Type 1 - New Molecular Entity

    11/25/24 8:41:11 AM ET
    $BBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    December 8, 2023 - FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

    For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signali

    12/8/23 11:12:21 AM ET
    $BLUE
    $VRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    FDA Approval for RUBRACA issued to CLOVIS ONCOLOGY INC

    Submission status for CLOVIS ONCOLOGY INC's drug RUBRACA (SUPPL-13) with active ingredient RUCAPARIB CAMSYLATE has changed to 'Approval' on 12/21/2022. Application Category: NDA, Application Number: 209115, Application Classification: Efficacy

    12/22/22 4:37:40 AM ET
    $CLVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADN
    $ADXN
    $AKRO
    $ALLK
    SEC Filings

    View All

    SEC Form 10-K filed by Calumet Inc.

    10-K - Calumet, Inc. /DE (0002013745) (Filer)

    2/27/26 4:02:59 PM ET
    $CLMT
    Integrated oil Companies
    Energy

    SEC Form 144 filed by Dream Finders Homes Inc.

    144 - Dream Finders Homes, Inc. (0001825088) (Subject)

    2/27/26 1:10:23 PM ET
    $DFH
    Homebuilding
    Consumer Discretionary

    Calumet Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Calumet, Inc. /DE (0002013745) (Filer)

    2/27/26 8:17:32 AM ET
    $CLMT
    Integrated oil Companies
    Energy

    $ADN
    $ADXN
    $AKRO
    $ALLK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Vincent Ron converted options into 556 shares and covered exercise/tax liability with 182 shares, increasing direct ownership by 0.22% to 173,009 units (SEC Form 4)

    4 - Crexendo, Inc. (0001075736) (Issuer)

    2/27/26 7:25:13 PM ET
    $CXDO
    Telecommunications Equipment
    Telecommunications

    Chief Executive Officer Korn Jeffrey G converted options into 556 shares and covered exercise/tax liability with 165 shares, increasing direct ownership by 0.16% to 239,582 units (SEC Form 4)

    4 - Crexendo, Inc. (0001075736) (Issuer)

    2/27/26 6:59:54 PM ET
    $CXDO
    Telecommunications Equipment
    Telecommunications

    Chief Operating Officer Gaylor Douglas Walter converted options into 556 shares and covered exercise/tax liability with 182 shares, increasing direct ownership by 0.14% to 263,346 units (SEC Form 4)

    4 - Crexendo, Inc. (0001075736) (Issuer)

    2/27/26 6:38:34 PM ET
    $CXDO
    Telecommunications Equipment
    Telecommunications

    $ADN
    $ADXN
    $AKRO
    $ALLK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Clear Channel Outdoor Holdings Inc.

    SC 13D/A - Clear Channel Outdoor Holdings, Inc. (0001334978) (Subject)

    12/4/24 5:00:38 PM ET
    $CCO
    Advertising
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Rocky Mountain Chocolate Factory Inc.

    SC 13D/A - Rocky Mountain Chocolate Factory, Inc. (0001616262) (Subject)

    11/29/24 2:00:08 PM ET
    $RMCF
    Specialty Foods
    Consumer Staples

    Amendment: SEC Form SC 13D/A filed by Satellogic Inc.

    SC 13D/A - Satellogic Inc. (0001874315) (Subject)

    11/27/24 4:30:03 PM ET
    $SATL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $ADN
    $ADXN
    $AKRO
    $ALLK
    Leadership Updates

    Live Leadership Updates

    View All

    Sana Biotechnology Appoints Brian Piper as Executive Vice President, Chief Financial Officer

    SEATTLE, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ:SANA), a company focused on changing the possible for patients through engineered cells, today announced the appointment of Brian Piper as Executive Vice President, Chief Financial Officer. Mr. Piper brings to Sana a breadth of biopharmaceutical financial and operational expertise with over 25 years of experience in various positions in the industry. Mr. Piper was most recently CFO of Scorpion Therapeutics and its post-acquisition spin-off, Antares Therapeutics. "I am thrilled to welcome Brian to Sana and to our leadership team," said Steve Harr, President and Chief Executive Officer of Sana. "He brings deep exper

    2/17/26 9:00:00 AM ET
    $SANA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Cipher Welcomes Thomas Duda to the Company's Board of Directors

    NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Cipher Mining Inc. (NASDAQ:CIFR) ("Cipher" or the "Company"), a leading developer and operator of industrial-scale data centers, today announces the appointment of Thomas Duda to its Board of Directors. Mr. Duda has more than twenty years of real estate-focused investment experience, further strengthening the Board as Cipher executes its pivot to becoming a world leader in data center development and operations. Mr. Duda currently serves as Vice President of Real Estate at Henry Crown and Company, where he leads the firm's real estate investment and asset management activities, and is a member of the Investment and Management Committee. Previous

    2/11/26 4:05:00 PM ET
    $CIFR
    Finance: Consumer Services
    Finance

    Sparrow Appoints Biopharmaceutical Industry Veteran, Carlo Incerti, M.D. to its Board of Directors

    BOSTON, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Sparrow Pharmaceuticals, a targeted cardiometabolic therapeutics company, today announced the appointment of Carlo Incerti, M.D., to its Board of Directors, effective January 1, 2026. Dr. Incerti is a highly accomplished executive with a strong background in medicine and over 35 years of strategic experience in the biopharmaceutical industry. "Carlo's appointment comes at a pivotal moment for Sparrow as we are looking ahead to pivotal trials of clofutriben for type 2 diabetes and seeking to expand development into other cardiometabolic indications," said Robert Jacks, Sparrow President and Chief Executive Officer. "Carlo is respected globally for

    2/2/26 8:30:00 AM ET
    $DYN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADN
    $ADXN
    $AKRO
    $ALLK
    Financials

    Live finance-specific insights

    View All

    Calumet Reports Fourth Quarter and Fiscal Year 2025 Results

    Fiscal Year 2025 net loss of $33.8 million, or basic loss per common share of $0.39Fiscal Year 2025 Adjusted EBITDA with Tax Attributes of $293.3 million$222 million of recourse debt reduction in 2025Strong free cash flow driven by approximately $100 million of cost reduction initiatives in 2025Record production year in Specialty Products & Solutions segment and Montana RenewablesMontana Renewables MaxSAF®150 expansion on track for second quarter of 2026INDIANAPOLIS, Feb. 27, 2026 /PRNewswire/ -- Calumet, Inc. (NASDAQ:CLMT) (the "Company," "Calumet," "we," "our" or "us")  today reported its results for the fourth quarter and year ended December 31, 2025, as follows: Three Months Ended Decemb

    2/27/26 7:00:00 AM ET
    $CLMT
    Integrated oil Companies
    Energy

    Range Increases Quarterly Dividend By 11%

    FORT WORTH, Texas, Feb. 27, 2026 (GLOBE NEWSWIRE) -- RANGE RESOURCES CORPORATION (NYSE:RRC) today announced that its Board of Directors declared a quarterly cash dividend on its common stock for the first quarter. A dividend of $0.10 per common share is payable on March 27, 2026 to stockholders of record at the close of business on March 13, 2026. This represents an 11% increase to Range's quarterly cash dividend and provides an annualized dividend of $0.40 per share. RANGE RESOURCES CORPORATION (NYSE:RRC) is a leading U.S. independent natural gas and NGL producer with operations focused in the Appalachian Basin. The Company is headquartered in Fort Worth, Texas.  More information about R

    2/27/26 7:00:00 AM ET
    $RRC
    Oil & Gas Production
    Energy

    Satellogic Schedules Fourth Quarter and Full Year 2025 Results Conference Call on Thursday, March 19, 2026 at 8:00 a.m. Eastern Time

    NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Satellogic, Inc. (NASDAQ:SATL), a vertically integrated geospatial company delivering high-resolution Earth Observation (EO) at unprecedented scale and economics, will hold a conference call on Thursday, March 19, 2026 at 8:00 a.m. Eastern time to discuss its results for the fourth quarter and fiscal year 2025 ended December 31, 2025, and will be providing updates on recent commercial advancements, partnerships, and other initiatives and milestones. Satellogic's Chief Executive Officer Emiliano Kargieman and Chief Financial Officer Rick Dunn will host the conference call, followed by a question-and-answer period. The conference call will be acco

    2/26/26 8:30:00 AM ET
    $SATL
    Radio And Television Broadcasting And Communications Equipment
    Technology